Enzyme-linked immunosorbent assay (ELISA) for IgA and IgG antibodies to Epstein-Barr-virus ribonucleotide reductase in patients with nasopharyngeal carcinoma. 1994

A Fones-Tan, and S H Chan, and S Y Tsao, and L H Gan, and W H Tan, and B Li, and P W Khong, and Y Y Gan
NIE, Nanyang Technological University, Singapore.

661 bp coding for the carboxyl end of the large sub-unit of EBV ribonucleotide reductase was cloned into the pMal plasmid vector. Purified recombinant protein was tested in IgG and IgA ELISAs. For the IgG assay, 81 out of 100 NPC patients tested positive, whereas for the IgA assay, 60 tested positive. Among 100 normal individuals, I tested positive for the IgG assay and 9 tested positive for the IgA assay. The IgG assay picked up 6 out of 19 NPC sera which were IFA-VCA- and IFA-EA-negative for IgA antibodies. Hence the recombinant ribonucleotide reductase could have good potential as a diagnostic test for NPC or could serve as a complementary test to IFA.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D009303 Nasopharyngeal Neoplasms Tumors or cancer of the NASOPHARYNX. Cancer of Nasopharynx,Nasopharyngeal Cancer,Cancer of the Nasopharynx,Nasopharynx Cancer,Nasopharynx Neoplasms,Neoplasms, Nasopharyngeal,Cancer, Nasopharyngeal,Cancer, Nasopharynx,Cancers, Nasopharyngeal,Cancers, Nasopharynx,Nasopharyngeal Cancers,Nasopharyngeal Neoplasm,Nasopharynx Cancers,Nasopharynx Neoplasm,Neoplasm, Nasopharyngeal,Neoplasm, Nasopharynx,Neoplasms, Nasopharynx
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012264 Ribonucleotide Reductases Ribonucleotide Reductase,Reductase, Ribonucleotide,Reductases, Ribonucleotide
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

A Fones-Tan, and S H Chan, and S Y Tsao, and L H Gan, and W H Tan, and B Li, and P W Khong, and Y Y Gan
April 1988, International journal of cancer,
A Fones-Tan, and S H Chan, and S Y Tsao, and L H Gan, and W H Tan, and B Li, and P W Khong, and Y Y Gan
March 1978, Zhonghua Minguo wei sheng wu xue za zhi = Chinese journal of microbiology,
A Fones-Tan, and S H Chan, and S Y Tsao, and L H Gan, and W H Tan, and B Li, and P W Khong, and Y Y Gan
May 1992, Medicina clinica,
A Fones-Tan, and S H Chan, and S Y Tsao, and L H Gan, and W H Tan, and B Li, and P W Khong, and Y Y Gan
January 1979, Comparative immunology, microbiology and infectious diseases,
A Fones-Tan, and S H Chan, and S Y Tsao, and L H Gan, and W H Tan, and B Li, and P W Khong, and Y Y Gan
February 1987, Clinica chimica acta; international journal of clinical chemistry,
A Fones-Tan, and S H Chan, and S Y Tsao, and L H Gan, and W H Tan, and B Li, and P W Khong, and Y Y Gan
March 1986, Annals of internal medicine,
A Fones-Tan, and S H Chan, and S Y Tsao, and L H Gan, and W H Tan, and B Li, and P W Khong, and Y Y Gan
December 1976, British journal of cancer,
A Fones-Tan, and S H Chan, and S Y Tsao, and L H Gan, and W H Tan, and B Li, and P W Khong, and Y Y Gan
January 1983, Acta microbiologica Hungarica,
A Fones-Tan, and S H Chan, and S Y Tsao, and L H Gan, and W H Tan, and B Li, and P W Khong, and Y Y Gan
March 1984, Journal of immunological methods,
A Fones-Tan, and S H Chan, and S Y Tsao, and L H Gan, and W H Tan, and B Li, and P W Khong, and Y Y Gan
October 1982, Journal of clinical pathology,
Copied contents to your clipboard!